Advanced glycation endproducts - Role in pathology of diabetic complications
DOI 10.1016/j.diabres.2004.09.004, PII S0168822704002943
N Ahmed 2005 Advanced glycation endproducts-role in pathology of diabetic complications Diab Res Clin Pract 67 3 21 10.1016/j.diabres.2004.09.004 1:CAS:528:DC%2BD2cXhtFGhsb7I (Pubitemid 40037725)
The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients
DOI 10.2337/diabetes.52.3.891
K Pettersson-Fernholm C Forsblom BI Hudson, et al. 2003 The functional -374T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients Diabetes 52 891 894 10.2337/diabetes.52.3. 891 1:CAS:528:DC%2BD3sXitFajtLc%3D 12606536 (Pubitemid 36323601)
G Prevost I Fajardy C Besmond, et al. 2005 Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients Diab Metab 31 35 39 10.1016/S1262-3636(07)70164-7 1:CAS:528:DC%2BD2MXivVOku7o%3D
E Lindholm E Bakhtadze M Sjogren, et al. 2006 The -374T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients Diabetologia 49 2745 2755 10.1007/s00125-006-0412-3 1:CAS:528:DC%2BD28XhtFOqsrrK 16969646
PE Lundmark U Liljedahl D Boomsma, et al. 2008 Evaluation of HapMap data in six populations of European descent Eur J Hum Genet 16 1142 1150 10.1038/ejhg.2008.77 1:CAS:528:DC%2BD1cXhtVWnsb3K 18398430
Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients
O Poirier V Nicaud N Vionnet, et al. 2001 Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients Diabetes 50 1214 1218 10.2337/diabetes.50.5.1214 1:CAS:528:DC%2BD3MXkvFSnsrc%3D 11334430
High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules
DOI 10.1073/pnas.82.17.5588
H Vlassara M Brownlee A Cerami 1985 High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules Proc Natl Acad Sci USA 82 5588 5592 10.1073/pnas.82.17.5588 1:CAS:528:DyaL2MXlvFeltr4%3D 2994035 (Pubitemid 16218810)
Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE
1:CAS:528:DC%2BD3MXjtFWntro%3D 11471552
CJ He T Koschinsky C Buenting H Vlassara 2001 Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE Mol Med 7 159 168 1:CAS:528:DC%2BD3MXjtFWntro%3D 11471552
Advanced glycation product (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
DOI 10.1073/pnas.0401588101
C Lu JC He W Cai H Liu L Zhu H Vlassara 2004 Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells Proc Natl Acad Sci U S A 101 11767 11772 10.1073/pnas.0401588101 1:CAS:528:DC%2BD2cXntVersrg%3D 15289604 (Pubitemid 39099304)
Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: Evidence for a protective role of galectin-3 as an AGE receptor
1:CAS:528:DC%2BD2cXpslehtb4%3D 15361471
C Iacobini S Menini G Oddi, et al. 2004 Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor FASEB J 18 1773 1775 1:CAS:528:DC%2BD2cXpslehtb4%3D 15361471
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes
10.2337/dc07-2306 1:CAS:528:DC%2BD1cXotVantr0%3D
M Saraheimo C Forsblom L Thorn, et al. 2008 Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes Diab Care 31 1165 1169 10.2337/dc07-2306 1:CAS:528:DC%2BD1cXotVantr0%3D